Ads
related to: merck- Treatment Efficacy
Learn More About Efficacy & Safety
Data for MAVENCLAD®.
- Dosing and Administration
Explore the Convenient Dosing
Schedule for MAVENCLAD®.
- Service Request Form
Download to Get Started
With MAVENCLAD® Today.
- Safety Profile
Discover Info About the Safety &
Tolerability Profile of MAVENCLAD®.
- Patient Support
Patient Resources for Navigating
The MAVENCLAD Treatment Journey
- Prescribing Info
Review Prescribing Information
For MAVENCLAD®.
- Treatment Efficacy
Search results
Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks· 3 days agoAlthough the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics ...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 3 days agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its...
Merck & Co., Inc. (MRK) Scheduled to Post Quarterly Earnings on Thursday
ETF DAILY NEWS· 5 days agoMerck & Co., Inc. (NYSE:MRK – Get Free Report) will announce its earnings results before the market opens on Thursday, April 25th. Analysts expect the company to announce ...
Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 3 days agoAlthough the revenue and EPS for Merck (MRK) give a sense of how its business performed in the...
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
Proactive Investors· 3 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after...
Here’s Why Merck & Co. (MRK) Outperformed in Q1
Insider Monkey via Yahoo Finance· 5 days agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be...
Merck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Results
Investopedia· 3 days agoMerck (MRK) shares advanced in intraday trading Thursday after the pharmaceutical firm reported...
Merck Earnings Preview: Strong quarter expectations on the back of core products' growth
Seeking Alpha· 4 days agoMerck (NYSE:MRK) is scheduled to announce Q1 earnings results on Thursday, April 25th, before market...
Scholz Gets Another Pharma Boost With New Merck KGaA Site
Bloomberg· 3 days agoMerck KGaA became the latest pharma company to begin construction of a new center in Germany,...
Merck hikes outlook for 2024 as Q1 print beats analyst estimates By Investing.com
Investing.com· 3 days agoMerck (MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked...